基本資料

投資策略

該基金之投資目標為以符合審慎的投資管理的原則下，謀求資本增值和日常益。該基金主要透過投資於世界各國政府及與政府有關的發行機構或企業機構所發行的固定或浮動利率債務證券（包括投資最高達該基金資產淨值的 5%於非投資級別證券）和償還債項。該基金亦可購買由數個國家政府所組織或支持的超國家機構所發行的償還債項。該基金可透過債券通或直接投資（亦稱為直接投資內地銀行間債券市場）少於其資產淨值的 30%於中國內地。無論何時，基金經理也不能把該基金 40%以上總淨資產投資於固定收益證券。

基金經理人

• Grant Douglas
• 資歷 3年(2022-04-11 至今)

• Mr. Grant joined Franklin Templeton in 2020. Prior to joining Franklin Templeton, Mr. Grant was a senior equity analyst at Sterling Capital.

• Taner Derek
• 資歷 3年(2022-04-11 至今)

• Derek Taner is the lead portfolio manger for the Invesco Global Health Care team. Mr. Taner joined Invesco in 2005, coming from Franklin Advisers Inc. where he served as a portfolio manager on Franklin Templeton’s health care team from 2002 through 2005 — the fi nal two years as lead manager. He began his investment career in 1993 as a fi xed-income analyst with Franklin Templeton and was promoted to assistant portfolio manager in 1997. In 2000, he joined the fi rm’s equity department and was named co-manager of its equity-income product. Mr. Taner earned a Bachelor of Science degree in business administration with an emphasis in accounting and fi nance and a Master of Business Administration degree from the Haas School of Business at the University of California (Berkeley). He is a CFA charterholder.

• Ho Calvin
• 資歷 6年(2018-12-31 至今)

• Calvin Ho, Ph.D., is a senior vice president and director of research for Templeton Global Macro. Dr. Ho also serves as a portfolio manager for a number of funds, including Templeton Global Bond Fund, Templeton Global Total Return Fund and Templeton Emerging Market Bond Fund. Dr. Ho joined Franklin Templeton Investments in 2005 after obtaining his Ph.D. at UC Berkeley. He has been a core part of the Templeton Global Macro team since 2005, working closely with Dr. Michael Hasenstab as a lead research analyst. Dr. Ho holds both B.A. and Ph.D. in economics from University of California, Berkeley.

基金費用

聯絡資訊